Biofil Chemicals

21
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE829A01014
  • NSEID: BIOFILCHEM
  • BSEID: 524396
INR
32.08
0.00 (0.00%)
BSENSE

Sep 24, 03:30 PM

BSE+NSE Vol: 11.56 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is -14.99% vs -16.57% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -23.36% vs 3.77% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -72.63% vs -11.08% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 399.55% vs -21.36% in Mar 2025

Compare Profit and Loss Results of Biofil Chemicals
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
28.00
28.00
0.00
0.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
28.00
28.00
0.00
0.00%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
5.00
-5.00
-100.00%
Raw Materials Consumed
26.00
16.00
10.00
62.50%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
5.00
-5.00
-100.00%
Operating Expenses
0.00
2.00
-2.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
27.00
34.00
-7.00
-20.59%
Operating Profit (PBDIT) excl Other Income
0.00
-6.00
6.00
100.00%
Other Income
3.00
1.00
2.00
200.00%
Operating Profit (PBDIT)
3.00
-5.00
8.00
160.00%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
3.00
-5.00
8.00
160.00%
Depreciation
0.00
2.00
-2.00
-100.00%
Profit Before Taxation & Exceptional Items
3.00
-7.00
10.00
142.86%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
3.00
-20.00
23.00
115.00%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
2.00
-21.00
23.00
109.52%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-31.00
-18.00
-13.00
-72.22%
Profit Available for appropriations
-28.00
-39.00
11.00
28.21%
Appropriations
-28.00
-39.00
11.00
28.21%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.71
-8.41
10.12
120.33%
Profit And Loss - Net Sales
Net Sales 28.40 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -14.99% vs -16.57% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.65 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -23.36% vs 3.77% in Mar 2025

Profit And Loss - Interest
Interest 0.01 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -72.63% vs -11.08% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 2.79 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 399.55% vs -21.36% in Mar 2025

Footer loading